A woman from Vermont brings the action against these drug companies after her father passed away from an life-threatening internal bleed which she (the plaintiff) claims was a result of her father’s exposure to Xarelto.
The complaint states that the decedent began taking Xarelto on July 17th, 2012 after being prescribed the drug by a medical professional for the treatment of atrial fibrillation. The decedent continued to take Xarelto as prescribed through approximately July 26th, 2012 at which point he suffered a life-threatening parenchymal hemorrhage, a type of bleeding within the brain.
The lawsuit alleges that the man’s irreversible bleeding injury was caused by his use of Xarelto and was a proximate cause in his premature death on August 1st, 2012.
In addition to several other allegations, this specific complaint claims that the defendants were negligent in their representation of Xarelto with regard to its efficacy and safety. The lawsuit also asserts that the defendants did not perform proper safety testing on Xarelto prior to its release.
The case was originally filed in the US District Court for the District of Vermont and has since been consolidated into the multidistrict litigation based in the US District Court for the Eastern District of Louisiana. To read the full complaint filed under case number 2:14-cv-00159, click here.
Xarelto: The #1 Blood Thinner In Its Class
Xarelto is a relatively new type of blood thinner drug (or anticoagulant) known as a Novel Oral Anticoagulant (NOAC) and has been prescribed more than 11 million times in America.
The drug was initially received approval from the Food and Drug Administration (FDA) on July 1st, 2011 for the treatment of deep vein thrombosis and pulmonary embolism in patients undergoing a knee or hip replacement surgery. Xarelto later received FDA approval for several other uses and is now approved for a total of six indications.
However, several medical studies have been published recently which link Xarelto to severe side effects such as uncontrollable internal bleeding.
About Xarelto Lawsuits
Recent discoveries of Xarelto’s allegedly harmful side effects have led many to take legal action against drug companies involved in the drug’s production, marketing and sales in the US.
Attorney Stephen A. Sheller, Esq. commented, “We are being contacted by individuals across the country who either suffered an injury while taking Xarelto or lost a loved one who had been taking Xarelto.”
“We are currently assisting these people in their pursuit of justice by helping file Xarelto lawsuit or by helping them find legal representation,” concluded Sheller of BloodThinnerHelp.com.